These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17515538)

  • 1. Cycad exposure and risk of dementia, MCI, and PDC in the Chamorro population of Guam.
    Borenstein AR; Mortimer JA; Schofield E; Wu Y; Salmon DP; Gamst A; Olichney J; Thal LJ; Silbert L; Kaye J; Craig UL; Schellenberg GD; Galasko DR
    Neurology; 2007 May; 68(21):1764-71. PubMed ID: 17515538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tales of Pacific tangles: Cycad exposure and Guamanian neurodegenerative diseases.
    Friedland RP; Armon C
    Neurology; 2007 May; 68(21):1759-61. PubMed ID: 17515536
    [No Abstract]   [Full Text] [Related]  

  • 3. Cycad neurotoxins, consumption of flying foxes, and ALS-PDC disease in Guam.
    Cox PA; Sacks OW
    Neurology; 2002 Mar; 58(6):956-9. PubMed ID: 11914415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Return of the cycad hypothesis - does the amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health?
    Ince PG; Codd GA
    Neuropathol Appl Neurobiol; 2005 Aug; 31(4):345-53. PubMed ID: 16008818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ALS/PDC syndrome of Guam and the cycad hypothesis.
    Steele JC; McGeer PL
    Neurology; 2008 May; 70(21):1984-90. PubMed ID: 18490618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of dementia in Chamorros on Guam: relationship to age, gender, education, and APOE.
    Galasko D; Salmon D; Gamst A; Olichney J; Thal LJ; Silbert L; Kaye J; Brooks P; Adonay R; Craig UK; Schellenberg G; Borenstein AR
    Neurology; 2007 May; 68(21):1772-81. PubMed ID: 17515539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A link between ALS and short residence on Guam.
    Majoor-Krakauer D; Mulder PG; Rowland LP; Ottman R
    Neurology; 2005 May; 64(10):1819-20. PubMed ID: 15911829
    [No Abstract]   [Full Text] [Related]  

  • 8. The ALS/PDC syndrome of Guam and the cycad hypothesis.
    Bradley WG; Banack SA; Cox PA
    Neurology; 2009 Feb; 72(5):473-4, 476; author reply 475-6. PubMed ID: 19195084
    [No Abstract]   [Full Text] [Related]  

  • 9. Seeking environmental causes of neurodegenerative disease and envisioning primary prevention.
    Spencer PS; Palmer VS; Kisby GE
    Neurotoxicology; 2016 Sep; 56():269-283. PubMed ID: 27050202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ALS/PDC syndrome of Guam and the cycad hypothesis.
    Borenstein AR; Mortimer JA; Schellenberg GD; Galasko D
    Neurology; 2009 Feb; 72(5):473, 476; author reply 475-6. PubMed ID: 19188582
    [No Abstract]   [Full Text] [Related]  

  • 11. Incidence of amyotrophic lateral sclerosis and of the parkinsonism-dementia complex of Guam, 1950-1989.
    Waring SC; Esteban-Santillan C; Reed DM; Craig UK; Labarthe DR; Petersen RC; Kurland LT
    Neuroepidemiology; 2004; 23(4):192-200. PubMed ID: 15272222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain volumes in Guam dementia vs Parkinson dementia complex vs aging Chamorro adults.
    Kaye JA; Moore MM; Galasko D; Craig UK; Adonay R; Silbert LC
    Neurology; 2007 Jul; 69(2):196-9. PubMed ID: 17620553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ALS/PDC syndrome of Guam and the cycad hypothesis.
    Cruz-Aguado R; Shaw CA
    Neurology; 2009 Feb; 72(5):474, 476; author reply 475-6. PubMed ID: 19195085
    [No Abstract]   [Full Text] [Related]  

  • 14. Biomagnification of cycad neurotoxins in flying foxes: implications for ALS-PDC in Guam.
    Banack SA; Cox PA
    Neurology; 2003 Aug; 61(3):387-9. PubMed ID: 12913204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of various forms of sterol beta-D-glucoside from the seed of Cycas circinalis: neurotoxicity and implications for ALS-parkinsonism dementia complex.
    Khabazian I; Bains JS; Williams DE; Cheung J; Wilson JM; Pasqualotto BA; Pelech SL; Andersen RJ; Wang YT; Liu L; Nagai A; Kim SU; Craig UK; Shaw CA
    J Neurochem; 2002 Aug; 82(3):516-28. PubMed ID: 12153476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining the interaction of apo E and neurotoxicity on a murine model of ALS-PDC.
    Wilson JM; Petrik MS; Moghadasian MH; Shaw CA
    Can J Physiol Pharmacol; 2005 Feb; 83(2):131-41. PubMed ID: 15791286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of tau pathologies in gray and white matter of Guam parkinsonism-dementia complex.
    Winton MJ; Joyce S; Zhukareva V; Practico D; Perl DP; Galasko D; Craig U; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2006 May; 111(5):401-12. PubMed ID: 16609851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Creating a Simian Model of Guam ALS/PDC Which Reflects Chamorro Lifetime BMAA Exposures.
    Banack SA; Cox PA
    Neurotox Res; 2018 Jan; 33(1):24-32. PubMed ID: 28478528
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Giménez-Roldán S; Steele JC; Palmer VS; Spencer PS
    J Hist Neurosci; 2021; 30(4):335-374. PubMed ID: 34197260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lessons from Guam ALS/PDC study].
    Asao H
    Rinsho Shinkeigaku; 2007 Nov; 47(11):717-21. PubMed ID: 18210783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.